PROTEIN ALTERNTIVES Chief Operating Officer Mr Juan Ignacio Imbaud has participated today in the second discussion panel “Boosting tech transfer in Biotechnology – turning ideas into technological solutions for society” at ASEBIO Investors Day organized by Asociación Española de Bioempresas.
The panel was moderated by Carolina Pola, Innovation Strategist at Kaudal, and included reference speakers of the innovation ecosystem like Clara Campàs Moya, CEO & Co-Founder of Asabys Partners, Esther Riambau, CEO of Oniria Therapeutics, and Antonio Gómez, Associate Director Alliance Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson.